Clinical Challenges: New Therapies for Relapsing MS

(MedPage Today) -- It wasn't that long ago (prior to 1993 and the approval of interferon beta-1b [Betaseron]) that no disease-modifying therapies to treat multiple sclerosis (MS) existed. Today, the approval of an ever-expanding array of such treatments...